Page 280 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.6. Patient characteristics—race/ethnicity (continued)
Author Database Race/ethnicity 1980- 1985-1989 1990-1994 1995-1999 2000- 2005- Statistical Notes
Year 1984 2004 2010 analysis
PMID
71
Greene CaPSURE White – non 83% 91% P<0.001
2005 Hispanic 11% 5% (chi-square
16194711 Black/African 2% 1% comparing
American 3% 1% 2 periods)
Asian 0% <1%
Hispanic 1% 1%
Alaska (1997- 99) (2000-
native/American 03)
native
Other
74
Mettlin NCDB Non-Hispanic 85.7% 85.1% NR
1995 White 1.6% 2.1%
8625214 Hispanic 7.6% 8.1%
African American 0.1% 0.1%
Native American 0.8% 1.1%
Asian 4.2% 3.5%
Unknown (1986-87) (1992)
75
Mettlin NCDB White – non 87.7% 83.3% NR
1998 Hispanic 8.8% 11.8%
9781963 Black/African 0.8% 1.6%
American 2.7% 3.3%
Hispanic (1992) (1995)
Other
77
Hamilton POCS, White 78.4% 83.2% P<0.01
2011 NCI African American 14.0% 12.5% (difference
20735387 Hispanic 7.6% 4.3% in
(1998) (2002) distribution
by yr)
92
White Texas Non-Hispanic 76.2% 73.5% Reference
2011 Cancer white 11.8% 12.2% P=0.148
21351084 Registry Non-Hispanic 11.5% 13.5% P<0.001
black 0.5% 0.8% P<0.001
Hispanic (1997) (2002) [chi-square
Asian/Pacific test for the
Islander racial
distribution
over time]
Ordering of the studies follows Appendix Table C1.1.
NA = not applicable; NR = not reported; PMID = PubMed identification number; RR = relative risk; yr = year.

C-58